BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.03 -0.01 (-25.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Restructuring Costs (2023 - 2025)

Updated

BioXcel Therapeutics' Restructuring Costs was $194,000 in FY2025, down 92.1% from $2.44 million in FY2024.

Analysis

BioXcel Therapeutics (BTAIQ) Restructuring Costs (2023 - 2025) Analysis & Trends

  • Per Business Quant data, Restructuring Costs in earlier years was $2.44 million in FY2024 (-41.4%) and $4.16 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 BioXcel Therapeutics 545,399.98 -94.07 Mn 160,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 194,000.00
Dec 31, 2024 33,000.00
Sep 30, 2024 1.55 Mn
Jun 30, 2024 856,000.00
Sep 30, 2023 4.16 Mn
API Access

BioXcel Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY